Chiba, Japan

Tomoya Uehara

USPTO Granted Patents = 3 


Average Co-Inventor Count = 3.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Tomoya Uehara: A Trailblazer in Antibody Development**

Introduction

Tomoya Uehara, a distinguished inventor based in Chiba, Japan, has made significant strides in the field of biomedicine through his innovative approaches to antibody design. With a portfolio of three patents, Uehara's contributions focus on enhancing the efficacy and safety of antibodies used in medical applications.

Latest Patents

Uehara's latest patents include groundbreaking methods for modifying antibodies and developing radioactive metal-labelled antibodies. One notable patent details a labeling technique aimed at optimizing liver metabolism post-administration without compromising antibody function. This innovation helps to minimize the accumulation of radionuclides in critical organs like the liver. Another patent describes a modified antibody that incorporates an IgG antibody complemented by an IgG-binding peptide, characterized by a specific amino acid sequence.

Additionally, Uehara's inventions encompass a metal complex forming compound, which can be coordinated with radioactive metals. This compound is further engineered for applications in radioactive drugs, radiotherapeutic agents, and diagnostic imaging, demonstrating Uehara’s commitment to advancing medical technology.

Career Highlights

Throughout his career, Uehara has collaborated with prominent institutions such as the National University Corporation Chiba University and Nihon Medi-Physics Company, Limited. His work in these organizations has allowed him to push the boundaries of current antibody applications and develop innovative solutions that address pressing medical challenges.

Collaborations

Uehara's journey has been marked by fruitful collaborations with esteemed colleagues in the field, including Yasushi Arano and Hiroyuki Suzuki. Together, they have shared knowledge and expertise, significantly contributing to the advancement of antibody technology and related fields.

Conclusion

Tomoya Uehara exemplifies innovation in the biomedical sector through his notable patents and collaborative efforts. His work not only paves the way for enhanced therapeutic methods but also provides an inspiration for future inventors in the realm of antibody development. Uehara's dedication to improving medical science underscores the vital role inventors play in shaping a healthier future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…